Nanobiotix S.A.
Stock Forecast, Prediction & Price Target
Nanobiotix S.A. Financial Estimates
Nanobiotix S.A. Revenue Estimates
Nanobiotix S.A. EBITDA Estimates
Nanobiotix S.A. Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $10K N/A | $4.77M 47660% | $30.05M 529.35% | Avg: $50.85M Low: $5.09M High: $116.43M avg. 69.20% | Avg: $64.36M Low: $24.10M High: $120.15M avg. 26.55% | Avg: $74.54M Low: $27.91M High: $139.15M avg. 15.80% | Avg: $79.25M Low: $29.67M High: $147.94M avg. 6.31% |
Net Income
% change YoY
| $-47.00M N/A | $-57.04M -21.35% | $-39.7M 30.40% | Avg: $-24.72M Low: $-83.74M High: $49.45M avg. 37.71% | Avg: $-6.81M Low: $-14.49M High: $-1.27M avg. 72.44% | Avg: $-4.46M Low: $-9.48M High: $-833.43K avg. 34.54% | Avg: $-24.58M Low: $-52.28M High: $-4.59M avg. -451.15% |
EBITDA
% change YoY
| $-40.99M N/A | $-51.80M -26.36% | $-30.08M 41.92% | Avg: $-48.72M Low: $-111.56M High: $-4.88M avg. -61.97% | Avg: $-61.67M Low: $-115.12M High: $-23.09M avg. -26.55% | Avg: $-71.42M Low: $-133.32M High: $-26.74M avg. -15.80% | Avg: $-75.93M Low: $-141.74M High: $-28.43M avg. -6.31% |
EPS
% change YoY
| -$1.35 N/A | -$1.64 -21.48% | -$1.08 34.14% | Avg: -$0.67 Low: -$2.27 High: $1.34 avg. 37.99% | Avg: -$0.18 Low: -$0.39 High: -$0.03 avg. 72.44% | Avg: -$0.12 Low: -$0.26 High: -$0.02 avg. 34.54% | Avg: -$0.67 Low: -$1.42 High: -$0.12 avg. -451.15% |
Operating Expenses
% change YoY
| $47.17M N/A | $46.70M -1.00% | $56.83M 21.69% | Avg: $25.50B Low: $2.55B High: $58.38B avg. 44772.88% | Avg: $32.27B Low: $12.08B High: $60.25B avg. 26.55% | Avg: $37.38B Low: $13.99B High: $69.77B avg. 15.80% | Avg: $39.74B Low: $14.88B High: $74.18B avg. 6.31% |
FAQ
What is Nanobiotix S.A. stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -76.61% in 2025-2028.
We have gathered data from 3 analysts. Their low estimate is -83.74M, average is -24.72M and high is 49.45M.
What is Nanobiotix S.A. stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 29.47% in 2025-2028.
We have gathered data from 3 analysts. Their low revenue estimate is $5.09M, average is $50.85M and high is $116.43M.
What is Nanobiotix S.A. stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -76.54% in 2025-2028.
We have gathered data from 3 analysts. Their low earnings per share estimate is -$2.27, average is -$0.67 and high is $1.33.